---
title: "Akari Therap (AKTX.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/AKTX.US/norm.md"
symbol: "AKTX.US"
name: "Akari Therap"
parent: "https://longbridge.com/en/quote/AKTX.US.md"
datetime: "2026-05-19T19:35:55.945Z"
locales:
  - [en](https://longbridge.com/en/quote/AKTX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AKTX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AKTX.US/norm.md)
---

# Akari Therap (AKTX.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -4.91 | -7.84 | -2.41 | -5.43 | -7.77 |
| ROE | -83.08% | -106.02% | -32.02% | -67.40% | -194.25% |
| Revenue | - | - | - | - | - |
| Net income | -5.30M | -6.40M | -1.90M | -3.71M | -3.77M |
| Operating income | -3.23M | -2.22M | -3.12M | -3.52M | -4.29M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 47.89M | 45.38M | 50.91M | 50.96M | 50.56M |
| Leverage | 1.69 | 2.00 | 1.99 | 2.34 | 2.27 |
| BVPS | 25.03 | 27.82 | 31.40 | 30.12 | 33.44 |
| Turnover | - | - | - | - | - |
| Cash & STI | 5.20M | 2.48M | 2.71M | 2.58M | 2.60M |
| Inv & Rec | - | - | - | - | - |
| LT assets | - | - | - | - | - |
| Net debt | -4.45M | -267000.00 | -1.16M | -736000.00 | 661000.00 |

## Cash Flow Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -3.04M | -2.12M | -3.26M | -2.15M | -2.12M |
| Investing CF | - | - | - | - | 382000.00 |
| Financing CF | 5.76M | 1.90M | 3.38M | 2.13M | 2.15M |
| Free CF | -3.20M | -2.72M | -4.52M | 808875.00 | 6.93M |
| OCF coverage | -2492.62% | -1050.00% | -1521.50% | -418.29% | -218.29% |
| Repaid & issued | 0.0000 | 2.10M | - | - | 0.0000 |
| CapEx | - | - | - | - | - |